Literature DB >> 24049963

Delusions of parasitosis.

Ethan C Levin1, Uwe Gieler.   

Abstract

The most common monosymptomatic hypochondriacal psychosis encountered by a dermatologist is delusions of parasitosis. In this condition, patients have an "encapsulated" fixed, false belief that they are infested with parasites or have foreign objects extruding from their skin. The patient will often experience feelings of biting, crawling and stinging related to the delusion. Most patients do not have other major psychiatric problems outside of their encapsulated delusion. The patient usually presents with a long history of symptoms and multiple visits to physicians in more than one specialty. Without an informed approach to these patients that focuses on the development of therapeutic alliance, clinical interactions can become very unpleasant. However, when treated with pimozide, risperidone, or other antipsychotic medications, patients have a very high response rate. Therefore, it is important for dermatologists to be able to handle these cases and know that the development of the therapeutic alliance is the key step to successful management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24049963     DOI: 10.12788/j.sder.0004

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

Review 1.  Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.

Authors:  Cody J Connor
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-20

2.  Health providers induced iatrogenic delusions of infestation.

Authors:  Pooja R Shah; Elizabeth Cusick; Yasmine Nousari; Andrea Sandoz; Francisco Tausk
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-11

3.  A comprehensive entomological survey and evaluation of the efficacy of different therapies on a suspected delusional parasitosis case.

Authors:  Parisa Soltan-Alinejad; Mozaffar Vahedi; Habibollah Turki; Aboozar Soltani
Journal:  Brain Behav       Date:  2020-11-11       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.